Intravenous blood thinner investigated in cardiogenic shock caused by acute myocardial infarction

Compared with crushed ticagrelor, intravenous cangrelor provided immediate, effective platelet inhibition, with no increase in major bleeding and lower mortality rates in patients with acute myocardial infarction and cardiogenic shock, according to late-breaking research presented in a Hot Line session at the ESC Congress 2025.

Facebook Comments